NeoGen PSR or Plasma Skin Regeneration is an FDA cleared, breakthrough technology in the medical aesthetics world to significantly reduce superficial and deep wrinkles, and improve skin elasticity and texture.
Plasma is the fourth state of matter that is different from solids, liquids, and gases. It's a gas that's highly dissociated. It was first discovered by British scientist William Crookes a century ago (1879). Flame is the most common plasma in life.
Nitrogen The chemical formula of nitrogen is N2. Under normal conditions, it is a colorless and odorless gas. Nitrogen accounts for 78% of the total amount of the atmosphere (the ion beam uses 99.99% or more of medical nitrogen). The biggest characteristic of nitrogen is that it will not burn. It can protect the epidermis from plasma burns when it is treated.
NeoGen PSR device converts nitrogen gas into plasma energy, the fourth state of matter. The ionized Nitrogen emerges from the handpiece in controlled pulses; and delivers rapid heating to the skin architecture stimulating a significant physiological response, without creating an open wound. Unlike ablative technologies, there is no epidermal vaporization or charring caused at the time of treatment.
The unique energy delivered by NeoGen PSR is non-fractionated and not dependent on a chromophore for its uptake. This provides uniform energy absorption, ensuring consistent treatment of the skin. At high energies it also supports significant tightening.
Unique deep tissue remodeling with rapid healing and no charringThe treated photo damaged layers undergo a controlled thermal modification, while remaining intact, creating a natural dressing to provide protection and speed healing. At high energies the epidermis sheds, but only after a new, healthier skin architecture is formed beneath.
Treating the entire skin structure ensures optimal results as the entire surface is regenerated with associated neocollagenesis and neoelastogenesis. No islands of untreated skin remain.
NeoGen is the ideal option for the treatment of the upper and lower eyelids, as well as the wider periorbital region. Other technologies cannot be used in this area or deliver inconsistent results.
Clinical studies show neocollagenesis and neoelastogenesis continuing for more than one year post treatment.
